| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |